The pathological changes of brain ECs in NgbrECKO mice are identical to that of ECs from human CCM lesions (9–11), such as increased RhoA/phos-MLC signaling and junctional disruption (42–44). The gene discussed is MLC1; the disease is cerebral cavernous malformation.